Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny tools, big promise: endoscopic procedures take on major GI surgery

NCT ID NCT03123835

Knowledge-focused Sponsor: University of California, Davis Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tracks 500 adults with conditions like acid reflux, achalasia, or complications after weight-loss surgery. Participants choose either a newer endoscopic procedure (done through a scope) or standard surgery. Researchers will compare how well each approach controls symptoms like heartburn and swallowing problems. The goal is to see if the less invasive options are as effective as traditional operations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Endoscopic procedure (endoluminal therapy, POEM, endoscopic revision)
What this could lead to
If successful, this could show that less invasive endoscopic treatments work as well as or better than traditional surgery for certain GI conditions.
What could go wrong
This is an observational study, not a controlled trial, so results may not prove which treatment is best. Outcomes depend on patient choice and surgeon skill.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Start date

Mar 2016

Expected to finish

Dec 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult male and female patients 18-80 years of age * Meet the criteria for surgery of benign and/or malignant gastrointestinal pathology(s) * Gastrointestinal Reflux Disease * Achalasia * Barrett's Esophagus * Post Bariatric Surgery conditions * Other gastrointestinal and postsurgical disorders. Exclusion Criteria: * Adults unable to consent * Individuals that do not meet inclusion criteria or qualify for endoluminal treatment paradigms and internees.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Achalasia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

achalasia Barrett esophagus Constriction, Pathologic Esophageal Achalasia Fistula Gastric Fistula gastric neoplasm gastroesophageal reflux disease gastrojejunal ulcer Obesity peptic ulcer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Achalasia Gastric fistula Gastric nec Marginal ulcer Stenoses Weight gain after primary weight loss surgery

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Univesity of California Davis Health System

    Sacramento, California, 95817, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.